Treatment of chronic allodynia in spinally injured rats: Effects of intrathecal selective opioid receptor agonists

Pain

Volumn 75, Issue 2-3, 1998, Pages 209-217

  Hao, Jing Xia ^a   Yu, Wei ^a   Wiesenfeld Hallin, Zsuzsanna ^a   Xu, Xiao Jun ^a  

^a Div Clin Neurophysiol   (Sweden)

Author keywords

Chronic pain; Intrathecal; Morphine; Neuropathic pain; Opioids; Splenic cord injury

Indexed keywords

3,4 DICHLORO N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRINDOLE; OPIATE; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; DRUG INTERACTIONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; FEMALE; HYPESTHESIA; INJECTIONS, SPINAL; NOCICEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SPINAL CORD INJURIES;

EID: 0344936723     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00221-2     Document Type: Article

References (50)

1. Arnér S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Arnér S., Meyerson B.A. Opioids in neuropathic pain. Pain Digest. 3:1993;15-22.
3. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
4. Bennett G.J. An animal model of neuropathic pain: a review. Muscle Nerve. 16:1993;1040-1051.
5. Besse D., Lombard M.C., Zagac J.M., Roques B.P., Besson J.M. Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521:1990;15-22.
6. Boivie, J., Central pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, London, 1994, pp. 871-892.
7. Bowsher D., Nurmikko T. Central post-stroke pain - drug treatment options. CNS Drugs. 5:1996;160-165.
8. Dickenson A.H., Knox R.J. Antagonism of μ-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn. Neurosci. Lett. 75:1987;229-234.
9. Drower E.J., Stapelfeld A., Rafferty M.F., de Costa B.R., Rice K.C., Hammond D.L. Selective antagonism by naltridole of the antinociceptive effects of the delta opioid agonist cyclic [D-penicillamine2-D-penicillamine5]enkephalin in the rat. J. Pharmacol. Exp. Ther. 259:1991;725-731.
10. Fujimoto J.M., Arts K.S. Rady. J.J. and Tseng, L.F., Spinal dynorphin A (1-17): possible mediator of antianalgesic action. Neuropharmacology. 29:1990;609-617.
11. Glynn, C., Jamous, M.A., Teddy, P.J., Moore, P.K. and Lloyd, J.W., The role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury, Lancet, ii (1986) 1249-1250.
12. Glynn C., Dawson D., Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non-cancer pain. Pain. 34:1988;123-128.
13. 125I]-FK-33-824-labelled mu opioid receptors in the spinal cord of normal and deafferented rats. Neuroscience. 43:1991;197-209.
14. Guirimand F., Strimbu-Gozariu M., Willer J.-C., Le Bars D. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat. J. Pharmacol. Exp. Ther. 269:1994;1007-1020.
15. Hammond, D., Do opioids relieve central pain. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: The Central Pain Syndromes, Raven Press, New York, 1991, pp. 233-242.
16. Hao J.-X., Yu W., Xu X.-J., Wiesenfeld-Hallin Z. Capsaicin-sensitive afferents mediate chronic cold, but not mechanical, allodynia-like behavior in spinally injured rats. Brain Res. 722:1996;177-180.
17. Hao, J.-X. and Xu, X.-J., Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists, Pain, 66 (1996a) 279-285.
18. Hao, J.-X. and Xu, X.-J., Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors, Pain, 66 (1996b) 313-319.
19. Hylden J.L., Nahin R.L., Traub R.J., Dubner R. Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons. Pain. 44:1991;187-196.
20. Knox R.J., Dickenson A.H. Effects of selective and non-selective κ-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones. Brain Res. 415:1987;21-27.
21. Kramer T.H., Shook J.E., Kazmierski W., Ayres E.A., Wire W.S., Hruby V.J., Burks T.F. Novel peptide mu opioid antagonists: pharmacological characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 249:1989;544-551.
22. Maekawa K., Minami M., Yabuuchi K., Toya T., Katao Y., Hosoi Y., Onogi T., Satoh M. In situ hybridization study of μ- and κ-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia. Neurosci. Lett. 168:1994;97-100.
23. Malmberg A.B., Yaksh T.L. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltridole and its benzofuran analog (NTB). J. Pharmacol. Exp. Ther. 263:1992;264-275.
24. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-313.
25. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
26. McQuay H.J., Jadad A.R., Carroll D., Faura C., Glynn C.J., Moore R.A., Liu Y. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anesthesiology. 47:1992;757-767.
27. Miaskowski C., Sutters K.A., Taiwo Y.O., Levine J.D. Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat. Brain Res. 553:1991;105-109.
28. Millan M.J. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli. J. Pharmacol. Exp. Ther. 251:1989;334-341.
29. Millan M.J. κ-Opioid receptors and analgesia. Trends Pharmacol. Sci. 11:1990;70-76.
30. Portoghese P.S., Sultana M., Takemori A.E. Naltridole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
31. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 43:1990;273-286.
32. Saeki S., Yaksh T.L. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. Anesth. Analg. 77:1993;265-274.
33. Schimauss C., Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J. Pharmacol. Exp. Ther. 228:1984;1-12.
34. Song Z.H., Takemori A.E. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception. Life Sci. 48:1991;1447-1453.
35. Storkson R.V., Kjorsvik A., Tjolsen A., Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods. 65:1996;167-172.
36. Stevens C.W., Seybold V.S. Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy. Brain Res. 687:1995;53-62.
37. Stewart P., Isaac L. Dynorphin-induced depression of the dorsal root potential in rat spinal cord: a possible mechanism for potentiation of the c-fiber reflex. J. Pharmacol. Exp. Ther. 259:1991;608-613.
38. Tiseo P.J., Yaksh T.L. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltridole: additional evidence for delta-opioid receptor subtypes in the rat. Eur. J. Pharmacol. 236:1993;89-96.
39. Tasker, R.R., Pain resulting from central nervous system pathology (central pain). In: J.J. Bonica (Ed.), The Management of Pain, Lea and Febiger, Philadelphia, PA, 1990, pp. 264-283.
40. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P., Porreca F. Single intrathecal injections of dynorphin or des-Tyr-dynorphins produces long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain. 68:1996;275-283.
41. Wiesenfeld-Hallin, Z., Hao, J.-X. and Xu, X.-J., Mechanisms of Central Pain. In: T.S. Jensen, J.A. Turner and Z. Wiesenfeld-Hallin (Eds.), Proc. 8th World Congress on Pain, Prog. Pain Res. Manage., Vol. 8, IASP Press, Seattle, WA, 1997, pp. 575-590.
42. Xu, X.-J., Hao, J.-X., Aldskogius, H., Seiger, A. and Wiesenfeld-Hallin, Z., Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury, Pain, 48 (1992a) 279-290.
43. Xu, X.-J., Hao, J.-X., Arner, S., Lindblom, U., Seiger, A. and Wiesenfeld-Hallin, Z., Systemic mexiletine relieves the chronic allodynialike symptoms in rats with ischemic spinal cord injury, Anesth. Analg., 74 (1992b) 649-652.
44. Xu X.-J., Hao J.-X., Seiger A., Hughes J., Hokfelt T., Wiesenfeld-Hallin Z. Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems. Pain. 56:1994;271-277.
45. Yaksh T.L. Opioid receptor systems and the endorphins: a review of their spinal organization. J. Neurosurg. 67:1987;157-176.
46. Yaksh, T.L., The spinal pharmacology of anomalous pain processing. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: The Central Pain Syndromes, Raven Press, New York, 1991, pp. 243-256.
47. Yezierski R.P. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 68:1996;185-192.
48. Yu, W., Hao, J.-X., Xu, X.-J. and Wiesenfeld-Hallin, Z., Comparison of the anti-allodynic and antinociceptive effects of systemic, intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain, Eur. J. Pain, 1 (1997a) 17-30.
49. Yu, W., Hao, J.-X., Xu, X.-J. and Wiesenfeld-Hallin, Z., The development of morphine tolerance and dependence in rats with chronic pain, Brain Res., 756 (1997b) 141-146.
50. Zeltser, R. and Seltzer, Z., A practical guide for the use of animal models in the study of neuropathic pain. In: J. Boivie, P. Hansson and U. Lindblom (Eds.), Touch, Temperature, and Pain in Health and Disease: Mechanisms and Assessments, Prog. Pain Res. Manage., Vol. 3, IASP Press, Seattle, WA, 1994, pp. 295-338.